Insulin Pills Market - Global Industry Size, Share, Trends, Competition, Opportunity and Forecast, 2016-2026 Segmented By Form (Tablet v/s Capsule), By Type of Insulin (Long-Acting Insulin, Short-Acting Insulin, Rapid-Acting Insulin), By Region
Published Date: November - 2024 | Publisher: MIR | No of Pages: 320 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationInsulin Pills Market - Global Industry Size, Share, Trends, Competition, Opportunity and Forecast, 2016-2026 Segmented By Form (Tablet v/s Capsule), By Type of Insulin (Long-Acting Insulin, Short-Acting Insulin, Rapid-Acting Insulin), By Region
Global insulin pills market is anticipated to project a robust growth in the forecast period, 2016-2026 with an impressive CAGR value on the account of increasing number of patients suffering from diabetes and irregular blood sugar level. Enhancement in the administration of the diabetic drugs is further driving the growth of the global insulin pills market in the upcoming five years.
Prevalence of Diabetes Drives Market Growth
Number of patients suffering from the abnormal blood sugar levels are increasing rapidly. The upsurge in the number of population and increasing instances of the diabetes is further aiding the growth of the global insulin pills market in the upcoming five years. Increasing geriatric population is highly susceptible to diseases like diabetes due to their prolonged exposure, genetic mapping, and weaker immunity to digest higher consumption of sugar is anticipated to drive the growth of the global insulin pills market in the next five years.
According to the latest data provided by International Diabetes Federation (IDF), more than 463 million people are currently suffering from diabetes globally. About 6% of the adult population in the European region is suffering from diabetes and the number is multiplying every year. The number of the population is anticipated to increase rapidly up to 700 million by the end of 2045. The sedentary lifestyle of the younger population is major reason behind the increasing population in the future years, thus anticipated to further drive the growth of the global insulin pills market in the forecast period.
Upcoming Product Launches Projects Further Growth
With the increase in the number of the patients suffering from the diabetes, market players are actively invested in launching innovative pharmaceutical products in the upcoming five years. Consistent research and development of the pharmaceutical products by various market players is substantiating the future growth of the global insulin pills market in the next five years.
Oramed Pharmaceutical Inc. is at a clinical trial stage with its drug ORMD-0801. The insulin capsule is focused to come up as the latest pharmaceutical for increasing demand for the oral insulin drug. The drug is anticipated to treat both type 1 and type 2 diabetes conditions. The company focuses on the formulation of capsules that can deliver insulin to the target organ. Since insulin is a protein, it has the tendency to get degraded and digested when ingested orally. Through its recent launch, the company is utilizing enteric coating and special protection which allows the insulin to stay intact through the GI tract and reach the intestinal wall. With added absorption enhancers, for intestinal walls, the insulin gets absorbed only in the insulin walls.
Preference to Oral Administration Over Injectables
Patients suffering from the higher costs of insulin injectables are highly concerned over injectables. Preferences toward oral administration of the insulin is increasing on various factors and driving the growth of the global insulin pills market in the next five years. Lack of awareness about the self-administration of insulin injections and the multiple times per day dosage of injectables is supporting the growth of the global insulin pills market in the upcoming five years. Moreover, injections are painful (for child population), inconvenient, and leave visible scars and make the patients dependent on the administration of insulin injections. Recent launches by various market players are coming up with the promise of reducing the costs of the pharmaceutical products thus supporting the future growth of the global insulin pills market in the future five years.
Market Segmentation
The global insulin pills market is segmented on the basis of form, type of insulin, competitional landscape, and regional distribution. Based on form, the market is further fragmented into tablet, and capsule. On the basis of type of insulin, the market is bifurcated into long-acting insulin, short-acting insulin, and rapid-acting insulin.
Company Profiles
Oramed Pharmaceuticals Inc., Novo Nordisk A/S, vTv Therapeutics Inc., Biocon Limited, Diabetology Ltd., NOD Pharmaceuticals, Inc
Click here to download the sample
| Attribute | Details |
| Base Year | 2020 |
| Historical Data | 2016 – 2019 |
| Estimated Year | 2021 |
| Forecast Period | 2022 – 2026 |
| Quantitative Units | Revenue in USD Million, and CAGR for 2016-2020 and 2021-2026 |
| Report Coverage | Revenue forecast, volume forecast, company share, competitive landscape, growth factors, and trends |
| Segments Covered |
|
| Regional Scope | North America; Europe; Asia Pacific; South America; Middle East & Africa |
| Country Scope | United States; Mexico; Canada; China; India; Japan; South Korea; Australia; Germany; France; United Kingdom; Spain; Italy; Saudi Arabia; UAE; South Africa; Kuwait; Brazil; Argentina; Colombia |
| Key Companies Profiled | Oramed Pharmaceuticals Inc., Novo Nordisk A/S, vTv Therapeutics Inc., Biocon Limited, Diabetology Ltd., NOD Pharmaceuticals, Inc. |
| Customization Scope | 10% free report customization with purchase. Addition or alteration to country, regional & segment scope. |
| Pricing And Purchase Options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
| Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy